Publication
Drug Resistance and Epigenetic Modulatory Potential of Epigallocatechin-3-Gallate Against Staphylococcus Aureus
| dc.contributor.author | Zeferino, AS | |
| dc.contributor.author | Mira, AR | |
| dc.contributor.author | Delgadinho, M | |
| dc.contributor.author | Brito, M | |
| dc.contributor.author | Ponte, T | |
| dc.contributor.author | Ribeiro, E | |
| dc.date.accessioned | 2022-12-06T15:17:03Z | |
| dc.date.available | 2022-12-06T15:17:03Z | |
| dc.date.issued | 2022 | |
| dc.description.abstract | Antimicrobial resistance of human pathogens, such as methicillin-resistant Staphylococcus aureus, is described by the World Health Organization as a health global challenge and efforts must be made for the discovery of new effective and safe compounds. This work aims to evaluate epigallocatechin-3-gallate (EGCG) epigenetic and modulatory drug potential against S. aureus in vitro and in vivo. S. aureus strains were isolated from commensal flora of healthy volunteers. Antibiotic susceptibility and synergistic assay were assessed through disk diffusion accordingly to EUCAST guidelines with and without co-exposure to EGCG at final concentrations of 250 µg/ml, 100 µg/ml, 50 µg/ml, and 25 µg/ml. Transcriptional expression of orfx, spdC, and WalKR was performed through qRT-PCR. A 90-day interventional study was performed with daily consumption of 225 mg of EGCG. Obtained data revealed a high prevalence of S. aureus colonization in healthcare workers and clearly demonstrated the antimicrobial and synergistic potential of EGCG as well as divergent resistant phenotypes associated with altered transcriptional expression of epigenetic and drug response modulators genes. Here, we demonstrate the potential of EGCG for antimicrobial treatment and/or therapeutic adjuvant against antibiotic-resistant microorganisms and report divergent patterns of epigenetic modulators expression associated with phenotypic resistance profiles. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Curr Microbiol . 2022 Apr 9;79(5):149 | pt_PT |
| dc.identifier.doi | 10.1007/s00284-022-02841-5 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.17/4300 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Springerlink | pt_PT |
| dc.subject | Antimicrobial resistance | pt_PT |
| dc.subject | Staphylococcus aureus | pt_PT |
| dc.subject | HCC PAT CLIN | pt_PT |
| dc.title | Drug Resistance and Epigenetic Modulatory Potential of Epigallocatechin-3-Gallate Against Staphylococcus Aureus | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.issue | 5 | pt_PT |
| oaire.citation.startPage | 149 | pt_PT |
| oaire.citation.title | Current Microbiology | pt_PT |
| oaire.citation.volume | 79 | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |